What is the ideal dose of Buscopan (hyoscine butylbromide) and Tamsulosin (alpha-blocker) for managing ureteric stone with chronic ureteric colic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing for Ureteric Stones with Chronic Ureteric Colic

For chronic ureteric colic from ureteral stones, use tamsulosin 0.4 mg once daily for stones 5-10 mm in the distal ureter; Buscopan (hyoscine butylbromide) is not recommended as it lacks evidence for stone passage and NSAIDs are superior for acute pain control.

Tamsulosin Dosing and Indications

The standard dose is tamsulosin 0.4 mg once daily, taken for up to 28-30 days or until stone passage occurs. 1, 2

Stone Size Criteria

  • For stones 5-10 mm in the distal ureter: Tamsulosin provides a 22-29% absolute increase in stone passage rates (81-87% vs 61-79% with placebo), with a number needed to treat of 4-5 patients 1
  • For stones ≤5 mm: Do not use tamsulosin—spontaneous passage rates are already 68-89% regardless of treatment, providing no clinically meaningful benefit 1
  • For stones >10 mm: Consider urologic intervention rather than medical expulsive therapy due to low spontaneous passage rates and high complication risk 1, 2

Duration and Monitoring

  • Continue tamsulosin for a maximum of 30 days 1
  • If the stone has not passed by 30 days, reassess for urologic intervention 1
  • Discontinue immediately if: infection/sepsis develops, renal function declines, or signs of obstruction requiring urgent intervention appear 1

Additional Benefits

  • Reduces time to stone expulsion by approximately 3 days 1
  • Decreases pain episodes and analgesic requirements 1
  • Works through alpha-1 receptor blockade causing ureteral smooth muscle relaxation 1, 2, 3

Buscopan (Hyoscine Butylbromide) - Not Recommended

Buscopan has no established role in medical expulsive therapy for ureteral stones. The available guidelines do not support its use for facilitating stone passage 4. While it is an antispasmodic, there is no evidence demonstrating efficacy for stone expulsion rates or long-term pain control in chronic ureteric colic.

Pain Management for Acute Exacerbations

For acute pain episodes during the stone passage period:

  • First-line: NSAIDs (diclofenac, ibuprofen, or metamizole) at the lowest effective dose 4
  • Second-line: Opioids other than pethidine (such as hydromorphine, pentazocine, or tramadol) if NSAIDs are contraindicated or insufficient 4
  • NSAIDs reduce the need for additional analgesia compared to opioids but may impact renal function in patients with low GFR 4

Important Caveats

Conflicting Evidence on Efficacy

Two large, high-quality randomized controlled trials from 2015 and 2018 found no benefit of tamsulosin over placebo for stone passage 5, 6. However, current guidelines from the American Urological Association and European Association of Urology continue to recommend tamsulosin based on earlier meta-analyses showing benefit, particularly for stones 5-10 mm 1, 2. The discrepancy may relate to patient selection, stone location confirmation, and study design differences.

Stone Location Matters

The greatest benefit is seen with distal ureteral stones confirmed on CT imaging 1. Proximal and mid-ureteral stones have less robust evidence for tamsulosin efficacy 4.

Comparative Alpha-Blockers

Tamsulosin, terazosin, and doxazosin appear equally effective for medical expulsive therapy, though tamsulosin has been most extensively studied 4, 2

References

Guideline

Tamsulosin for Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alpha Blockers for Facilitating Stone Passage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.